Chris Cardon, Ziphius Vaccines CEO
May 25, 2021 10:26 AM EDT
Financing
Coronavirus

Spurred on by Mod­er­na and Pfiz­er's suc­cess, a Bel­gian biotech has big am­bi­tions for its self-am­pli­fy­ing RNA vac­cine play

Josh Sullivan

With the first wave of mR­NA-based Covid-19 vac­cines pro­vid­ing proof of con­cept to the en­tire field, in­vestors are see­ing dol­lar signs for plat­form plays once …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Pfiz­er look­ing to sell hos­pi­tal drugs unit — re­ports

As­traZeneca CEO reaf­firms com­mit­ment to Chi­na fol­low­ing ex­ec­u­tive's de­ten­tion

'Ex­per­tise is a re­al thing': FDA com­mis­sion­er warns of po­lit­i­cal risk to agency

Mer­ck, As­traZeneca tout Phase 3 win for can­cer-turned-rare dis­ease drug

No­var­tis pays $150M up­front to Schrödinger in new drug deal, ramps up soft­ware use

sponsored

What Will It Take to Re­verse Fi­bro­sis in Pa­tients with Ad­vanced MASH?

A service from the Financial Times